SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
149.20    -16.60 (-10.01%)
Bid:
149.20
Ask:
150.20
Spread: 1.00 (0.67%)
Market Cap: £254.93m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Director Appointment

10 Mar 2026 07:00

RNS Number : 9495V
McBride PLC
10 March 2026
 

10 March 2026

McBride plc

Director Appointment

 

McBride plc (the 'Company'), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning/hygiene markets, announces the appointment of Casper Meijer as an independent Non-Executive Director with effect from 10 March 2026. 

Casper has extensive experience in the retail sector across a wide range of categories, such as garden, pet, outdoor living, food, household goods and discount retail, in both local and international companies. He brings specific expertise in private label, category management and sustainable innovation.

Presently, Casper is the Chief Executive Officer of Welkoop, a Dutch retail chain that focuses on garden, pet and outdoor living products. In addition, Casper is a Non-Executive Director of Fiksuruoka, a Finnish company (which trades as Foodello outside of Finland) that has become one of the leading food‑waste‑reduction retailers in Europe. Previously, Casper was the Chief Executive Officer of Blokker Holding (now known as Mirage Retail Group), a Dutch retail conglomerate that has owned and operated many of the Netherlands' best‑known non‑food store chains. He has also held the position of Group Trading Director at Morrisons plc, the UK supermarket chain and was Commercial Director and Board member at Albert Heijn. Contemporaneously with joining the Board, Casper will become a member of the Audit and Risk, Nomination and Remuneration Committees of the Company.

McBride has been advised that there are no other details which require disclosure under UK Listing Rule 6.4.8. Casper does not have any interest in the shares of McBride.

Jeff Nodland, Chairman, said: "On behalf of the Board, I am delighted to welcome Casper to McBride. His wealth of experience, particularly in retail in mainland Europe, will further strengthen the Board. The Directors and I look forward to working with Casper as we continue to focus on the Company's key objectives in the months and years ahead."

 

ENDS

For further information, please contact:

 

McBride plc

via TEAM LEWIS

Jeff Nodland, Chairman

Chris Smith, Chief Executive Officer

 

 

Team Lewis

Hannah Scott

Galyna Kulachek

 

+44 20 7802 2634

+44 20 7802 2664

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUKRARNWUORUR
Date   Source Headline
12th Jun 20267:00 amRNSTrading and Acquisition Update
11th Jun 20261:44 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSSecond tranche of share buyback programme
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSProposed Acquisition & Trading Conditions Update
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector Appointment
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20266:28 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:05 amRNSInterim results for 6M ended 31 December 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.